TELA Bio (TELA) Other Accumulated Expenses (2018 - 2026)

TELA Bio has reported Other Accumulated Expenses for 9 years, with the latest figure at $363000.0 in Q2 2026.

• On a quarterly basis, Other Accumulated Expenses fell 70.89% year-over-year to $363000.0 in Q2 2026; TTM through Jun 2026 was $363000.0, a 70.89% decrease from a year earlier, with the FY2025 full-year figure at $711000.0, up 48.43% from the prior year.
• Other Accumulated Expenses was $363000.0 for Q2 2026 at TELA Bio, down from $546000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $1.2 million in Q2 2025, with the low at $51000.0 in Q1 2022.
• Average Other Accumulated Expenses over 5 years is $524111.1, with a median of $503000.0 recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Other Accumulated Expenses plunged 91.72% in 2022, then soared 285.9% in 2024.
• Over 5 years, Other Accumulated Expenses stood at $146000.0 in 2022, then soared by 260.96% to $527000.0 in 2023, then dropped by 9.11% to $479000.0 in 2024, then jumped by 48.43% to $711000.0 in 2025, then plunged by 48.95% to $363000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $363000.0 (Q2 2026), $546000.0 (Q1 2026), and $711000.0 (Q4 2025), per Business Quant data.